Cancer Research Cancer Epigenetics Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lancaster, J. R.
Right arrow Articles by Xie, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lancaster, J. R., Jr.
Right arrow Articles by Xie, K.
Related Collections
Right arrow Cellular Pathobiology
Right arrow Cellular Pathobiology: DNA Damage and Stress Responses
[Cancer Research 66, 6459-6462, July 1, 2006]
© 2006 American Association for Cancer Research

Reviews

Tumors Face NO Problems?

Jack R. Lancaster, Jr.1 and Keping Xie2

1 Center for Free Radical Biology, Departments of Anesthesiology, Physiology and Biophysics, and Environmental Health Sciences, The University of Alabama at Birmingham, Birmingham, Alabama and 2 Departments of Gastrointestinal Medical Oncology and Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Keping Xie, Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-792-2828; Fax: 713-745-1163; E-mail: kepxie{at}mail.mdanderson.org.

The effect of nitric oxide (NO) synthase (NOS) II expression on cancer biology is unclear and difficult to define, with multiple reports of pro- and anti-cancer actions. Here we address the major factors that seem likely to account for these paradoxical behaviors, which include variability in NO production, heterogeneity in NO chemistry (and thus its cellular actions), and differential cellular responses. In addition, we suggest that a major determinant of the outcome of NO actions in the tumor environment is cellular adaptation/selection to the cytotoxic actions of NO. (Cancer Res 2006; 66(13): 6459-62)




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
J.-Y. Choi, W. E. Barlow, K. S. Albain, C.-C. Hong, J. G. Blanco, R. B. Livingston, W. Davis, J. M. Rae, I-T. Yeh, L. F. Hutchins, et al.
Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical Trial
Clin. Cancer Res., August 15, 2009; 15(16): 5258 - 5266.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q. Du, X. Zhang, J. Cardinal, Z. Cao, Z. Guo, L. Shao, and D. A. Geller
Wnt/{beta}-Catenin Signaling Regulates Cytokine-Induced Human Inducible Nitric Oxide Synthase Expression by Inhibiting Nuclear Factor-{kappa}B Activation in Cancer Cells
Cancer Res., May 1, 2009; 69(9): 3764 - 3771.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K.-M. Lee, D. Kang, S. K. Park, S. I. Berndt, D. Reding, N. Chatterjee, S. Chanock, W.-Y. Huang, and R. B. Hayes
Nitric oxide synthase gene polymorphisms and prostate cancer risk
Carcinogenesis, April 1, 2009; 30(4): 621 - 625.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Feelisch, B. O. Fernandez, N. S. Bryan, M. F. Garcia-Saura, S. Bauer, D. R. Whitlock, P. C. Ford, D. R. Janero, J. Rodriguez, and H. Ashrafian
Tissue Processing of Nitrite in Hypoxia: AN INTRICATE INTERPLAY OF NITRIC OXIDE-GENERATING AND -SCAVENGING SYSTEMS
J. Biol. Chem., December 5, 2008; 283(49): 33927 - 33934.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. P. Hussain, P. He, J. Subleski, L. J. Hofseth, G. E. Trivers, L. Mechanic, A. B. Hofseth, M. Bernard, J. Schwank, G. Nguyen, et al.
Nitric Oxide Is a Key Component in Inflammation-Accelerated Tumorigenesis
Cancer Res., September 1, 2008; 68(17): 7130 - 7136.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Yang, C. B. Ambrosone, C.-C. Hong, J. Ahn, C. Rodriguez, M. J. Thun, and E. E. Calle
Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer
Carcinogenesis, June 1, 2007; 28(6): 1247 - 1253.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Zhao, M. Mohaupt, J. Jiang, S. Liu, B. Li, and Z. Qin
Tumor Necrosis Factor Receptor 2-Mediated Tumor Suppression Is Nitric Oxide Dependent and Involves Angiostasis
Cancer Res., May 1, 2007; 67(9): 4443 - 4450.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Ying and L. J. Hofseth
An Emerging Role for Endothelial Nitric Oxide Synthase in Chronic Inflammation and Cancer
Cancer Res., February 15, 2007; 67(4): 1407 - 1410.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.